Biological scaffold material, 3D printing scaffold and preparation method

By developing a 3D printed biological scaffold material containing linear polyurethane, hydroxyapatite and inorganic nanofillers, the problem of limited material selection in the prior art is solved, and the orderly porous with excellent performance is achieved at room temperature is achieved. Biostents expand the application range of 3D printing technology.

CN119034004APending Publication Date: 2024-11-29THE AFFILIATED STOMATOLOGICAL HOSPITAL OF KUNMING MEDICAL UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411289872.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-14
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing 3D printing technology has limitations in material selection and cannot support the printing of multiple materials, especially materials with high heat resistance, flexibility and stability requirements, resulting in limited application range.

Method used

Develop a 3D printing-based biostent material, including linear polyurethane, hydroxyapatite, inorganic nanofillers and drugs, and prepare materials in fluid state at room temperature through specific formulations and preparation methods for the preparation of excellent Performance of 3D printed biostents. The material is copolymerized by aliphatic diisocyanate hard segment and a hydroxyl-containing diol polymer soft segment, combined with hydroxyapatite and inorganic nanofillers, and combined with an appropriate amount of solvent to form a biological scaffold material with appropriate viscosity and structure.

Benefits of technology

It realizes 3D printed biological scaffold material used at room temperature, and can print scaffolds with an ordered porous structure. The pore size and porosity are adjustable, providing a wider selection of materials, improving the application range of 3D printing technology and biological scaffolding. performance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119034004A_ABST
    Figure CN119034004A_ABST
Patent Text Reader

Abstract

The invention discloses a biological scaffold material, a 3D printing scaffold and a preparation method. The biological scaffold material is in a fluid state at room temperature. The biological scaffold material is prepared from the following components in parts by weight: 0-50wt% of linear polyurethane, 0-30wt% of hydroxyapatite, 0-5wt% of inorganic nano filler, 0-5wt% of a mixture of the medicine and the solvent and the balance of linear polyurethane, and the invention provides a preparation method of the biological scaffold material. Meanwhile, the invention also provides an ordered porous scaffold and a preparation method of the scaffold.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a tissue repair scaffold used in the field of biomedicine, and in particular to a biological scaffold material, a 3D printed scaffold and a preparation method thereof. Background Art

[0002] Millions of surgeries are performed each year involving tissue filling and repair. Current advanced scaffold design technology, bioactive factors and cell culture technology indicate that tissue engineering has a promising future. As one of the three elements, scaffolds are an important component of tissue engineering. The core of scaffolds is to provide a template for cell attachment and stimulation of bone tissue formation by simulating the extracellular matrix (such as mechanical support, cell activity and proteins produced through biochemical and mechanical interactions). In the early stages of regeneration and repair, cells attach to the edge of the implanted scaffold and gradually migrate and mineralize inside. The through holes allow nutrients and protein molecules to be transported to the inside of the scaffold to promote cell entry, vascularization and waste removal. Therefore, tissue engineering scaffolds with precise structural design can better meet the requirements of performance design.

[0003] In addition, the material properties of different scaffolds affect the adhesion, proliferation and differentiation of cells. Structural factors such as the pore size, porosity and interconnected pore structure of porous materials and factors such as the surface roughness, chemical composition, surface hydrophilicity, surface energy and surface charge of the material all affect the growth of new tissues. Since the 1970s, there have been a lot of research on porous biomaterials, mainly including ceramics, polymers and metals. In the process of material preparation, it is first necessary to simulate the through-porous structure of bones so that blood vessels can grow in to achieve a good repair effect. For the preparation of porous materials, there are mainly electrospinning technology, particle pore method, gas foaming method, freeze-drying method, emerging 3D printing technology, etc.

[0004] 3D printing technology can easily manufacture objects with complex structures, and the process is simple and low-cost; it can make complex large parts integrated without assembly, saving labor and transportation costs; its design space is unlimited, breaking through the limitations of traditional processing and opening up a huge design and molding space; 3D printers have a high degree of automation, occupy less space, and have stronger manufacturing capabilities; they can maximize the use of materials, are more environmentally friendly and more economical; it can also directly fuse raw materials of different colors and performances together to form new materials, giving them unique properties or functions; 3D technology also has the ability to accurately replicate entities, and can scan, edit and copy physical objects to create accurate copies or restore them to their original state. At present, breakthroughs in 3D printing materials and processes have given it higher dimensional accuracy, smaller scale (such as nanoscale) and faster speed.

[0005] In addition, 3D printing technology has been widely used in medicine. Recently, bioprinting of complex structures has emerged in tissue engineering. This includes free-form bioprinting, such as: Highley et al. developed bio-inks based on supramolecular assembly and hydrogels for support, which can achieve rapid self-repair. Using this technology, discrete structures can be 3D printed by adjusting parameters. At present, high-resolution 3D printing technology has also emerged, which can be developed by combining electrospinning technology with robots and can print at the micro and nano scales. In addition, in situ bioprinting has also developed rapidly. Li et al. first scanned the exact shape of a large segment of bone defect, and then used sodium alginate and hydrogel to directly and quickly print in situ. If the 3D printed structure can change its shape or structure over time (generally external stimuli, such as pH, temperature, electricity, ionic strength, light, magnetic field, pressure, sound waves, etc.), we call it 4D printing. Miao et al. developed a material with shape memory properties based on soybean oil epoxidized acrylate. They fixed the material into a temporary shape at 18°C ​​and completely restored it to its original state at 37°C.

[0006] Although a large number of new methods and means of 3D printing have been reported, many problems have been solved, and many functions have been given to materials. But its first stumbling block is the limitation of the required materials. Although high-end industrial printing can realize the printing of some plastics, metals and ceramics, it has not yet reached a mature level and cannot support a variety of materials in life. At present, there are only more than 200 materials suitable for 3D printing, and they have extremely high requirements for heat resistance, flexibility, stability and sensitivity. Therefore, in order to make the application of 3D printing technology wider and better benefit mankind, it is particularly important to develop new 3D printing materials. Summary of the invention

[0007] The present invention provides a biological scaffold material, a 3D printing scaffold and a preparation method to address the deficiencies of the above-mentioned prior art, provides a material that is in a fluid state at room temperature and can serve as 3D printing "ink", and provides a preparation method for the material, thereby obtaining a 3D printing biological scaffold with excellent performance.

[0008] In order to achieve the purpose of the present invention, the following technologies are proposed: A 3D-printed biological scaffold material that is in a fluid state at room temperature; And includes, by weight, linear polyurethane, hydroxyapatite, inorganic nanofiller, drug and solvent; Hydroxyapatite accounts for 0-50wt% of the total mass; Inorganic nanofillers account for 0-30wt% of the total mass; The mixture of drug and solvent accounts for 0-5wt% of the total mass; The balance is linear polyurethane; Furthermore, the contents of linear polyurethane, hydroxyapatite, inorganic nanofiller, drug and solvent are as follows in parts by weight: Hydroxyapatite accounts for 30-45wt% of the total mass; Inorganic nanofillers account for 10-20wt% of the total mass; The mixture of drug and solvent accounts for 2-5wt% of the total mass; The balance is linear polyurethane.

[0009] Furthermore, the linear polyurethane is polymerized by hard segment material of aliphatic diisocyanate and soft segment material of diol polymer and / or block copolymer containing hydroxyl group, and the molecular weight of the linear polyurethane is 10000-100000, preferably 30000-50000.

[0010] The molar ratio of the isocyanate group in the hard segment material to the hydroxyl group in the soft segment material is (2-4):1; preferably (2-3):1.

[0011] The hard segment material includes at least one of isophorone diisocyanate, 4,4'-dicyclohexylmethane diisocyanate and lysine diisocyanate, preferably isophorone diisocyanate.

[0012] The soft segment component is a linear diol with a molecular weight of 1000-20000, including at least one of polycaprolactone diol, polylactic acid diol, polyglycolide diol, and polylactic acid-glycolic acid copolymer diol, preferably polytetramethylene glycol diol and / or polycaprolactone diol with a molecular weight of 2000.

[0013] Furthermore, hydroxyapatite includes common hydroxyapatite, carbonate hydroxyapatite, and silicate-substituted hydroxyapatite.

[0014] Hydroxyapatite is spherical with a diameter of 10-1000nm; Granular with a particle size of 10-1000nm; Flakes with a diameter of 10-100nm and a thickness of 10-50nm; One or more nanocrystals in the shape of rods with a diameter of 10-100nm and a length of 10-500nm.

[0015] Furthermore, the inorganic nanofiller is silicon dioxide and nano barium titanate with a particle size less than 1000 nm, and the particle size is 100-500 nm.

[0016] Furthermore, the drug is deferoxamine.

[0017] Furthermore, the solvent is at least one of deionized water, ethanol, chloroform, trifluoroethanol, chloroform, dichloromethane, hexafluoroisopropanol, tetrahydrofuran, acetone, N,N-dimethylformamide, and N,N-dimethylacetamide, preferably ethanol.

[0018] Furthermore, its apparent viscosity is 100-1000 Pa·s, preferably 150-500 Pa·s.

[0019] In addition, a method for preparing a biological scaffold material based on 3D printing is provided, which is used to prepare the biological scaffold material based on 3D printing, comprising the steps of: Step A1, the hard segment material and the soft segment material are stirred and reacted at 60-110° C. for 2-6 hours under nitrogen protection; Step A2, adding a chain extender with a molar mass of 1:(1-2) of the soft segment material and a catalyst with a molar mass of 0.01-0.05 wt% of the mass of the soft segment material to react for 1-5 hours; The chain extender is at least one of ethyl lysine ester dihydrochloride, 1,4-butanediol, ethylene glycol and 1,6-hexanediol. The catalyst is at least one of dibutyltin dilaurate, stannous octoate and stannous chloride. Step A3, adding 0.1-1 mL of deionized water and foaming reaction at 90-110° C. for 2-24 hours to obtain foamed polyurethane; Step A4, cutting the foamed polyurethane into granules, drying and then putting them into a solvent, so that the granular foamed polyurethane is dissolved in the solvent; Step A5, treating the hydroxyapatite and the inorganic nanofiller with a silane coupling agent at 90-110° C. for 2-5 hours respectively; The general formula of the silane coupling agent is RSiX3, wherein R represents amino, mercapto, vinyl, epoxy, cyano, methacryloyloxy and other groups, and X represents a hydrolyzable group, such as halogen, alkoxy, acyloxy, etc.; Step A6, adding hydroxyapatite and inorganic nanofiller to the solution obtained in step A4 and dispersing by ultrasonication; Step A7, adding the drug to the solution obtained in step A5, and waiting for the drug to dissolve to obtain a bioscaffold preparation material.

[0020] In addition, a 3D printing-based biological scaffold is provided, which is an ordered porous scaffold prepared by using the 3D printing-based biological scaffold material and a deposition 3D printing method.

[0021] The ordered porous support has longitudinal through holes with a pore size of 50-1000 μm and transverse through holes with a pore size of 10-1000 μm.

[0022] The ordered porous scaffold material has a density of 50-100 kg / m 3 , elastic material with porosity of 0-90% and compression strength of 0.5-5MPa.

[0023] In addition, a method for preparing a biological scaffold based on 3D printing is also provided, wherein the biological scaffold material based on 3D printing is added into the barrel of a 3D printer, and the biological scaffold is prepared by a 3D printer. During the preparation, the prepared scaffold is received by a container containing a solvent for replacing and curing the biological scaffold material, and the operating parameters are: The layer height of the printed model is 0.1-1mm, preferably 0.2-0.3mm; The diameter of the printing wire is 0.21-1 mm, preferably 0.21-0.36 mm; The printing wire spacing is 0-1mm, preferably 0.4-0.7mm; The printer needle pressure is 1-5MPa; The needle running speed is 0.1-8 mm / s, preferably 2-3 mm / s; The slurry bin temperature is 0-60°C, preferably 40-50°C; The receiving plate temperature is -10-50°C, preferably 30-40°C; The ambient temperature is 10-40°C, preferably 25°C; The relative humidity is 20-70%, preferably 30-50%.

[0024] The filament diameter of 3D printed biological scaffold materials is directly related to the needle used in the printing process, the printing speed and the applied air pressure. For example, for the printing of biological scaffolds, a needle with a needle tip diameter of 0.21 mm is used for printing. When the printing speed is set to 4 mm / s and a pressure of 5 MPa is applied to the barrel, the diameter of the 3D printed filament is 0.2-0.22 mm. When the printing speed is set to 6 mm / s and a pressure of 4 MPa is applied to the barrel, the diameter of the 3D printed filament is 0.15-0.17 mm. However, in order to ensure the continuity of the filament and the smoothness of the printing process, for biological scaffold materials, the corresponding printing speed and applied air pressure need to be adjusted to ensure that the diameter of the 3D printed filament is 0.7-0.9 times that of the needle. The layer height set during 3D printing is also directly related to the diameter of the 3D printed filament. During the printing process, it is necessary to keep the overlap between adjacent layers of filaments at 20%-50%. The higher the overlap ratio, the lower the porosity of the formed scaffold and the higher the compression strength. The spacing between 3D printing filaments is adjusted according to the diameter of the 3D printing filaments, and the longitudinal aperture must be between 0.3 and 1 mm.

[0025] The advantages of the above technical solution are: The bioscaffold material provided by the present invention can act as "ink" during 3D printing, thereby facilitating 3D printing operations. The bioscaffold provided by the present invention is an ordered porous scaffold having longitudinal through holes with a pore size of 50-1000 μm and transverse through holes with a pore size of 10-1000 μm. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] In order to make the objectives, technical solutions and advantages of the present invention more clear, the present invention will be further described in detail below with reference to the accompanying drawings.

[0027] Figure 1 The bioscaffold prepared in Example 1 is shown.

[0028] Figure 2 The component analysis diagram of the biological scaffold is shown, wherein CHA is cyclohexylamine, PU is polyurethane, PUH is a combination of hydroxyapatite and PU, and PUHB is a combination of hydroxyapatite + barium titanate and PU.

[0029] Figure 3 The microstructure morphology of the 3D printed bioscaffold containing the polyurethane / hydroxyapatite composite in Example 4 is shown, wherein Figure a is a structural diagram of the porous three-dimensional scaffold, Figure b is the microstructure morphology of the low-magnification porous three-dimensional scaffold, and Figure c is the microstructure morphology of the high-magnification porous three-dimensional scaffold.

[0030] Figure 4 The microstructure morphology and element distribution of the barium titanate / hydroxyapatite / polyurethane composite 3D printed biological scaffold in Example 6 are shown. Among them, Figure a is the microstructure morphology of the polymerase chain reaction result, Figure b is the local magnified microstructure morphology, Figure c is the distribution diagram of the C element, Figure d is the distribution diagram of the O element, Figure e is the distribution diagram of the Ca element, Figure f is the distribution diagram of the P element, Figure g is the distribution diagram of the Ti element, and Figure h is the distribution diagram of the Ba element.

[0031] Figure 5 The quantitative analysis of Col Ⅰ (a), OCN (b) and Runx2 (c) expression of cells on barium titanate / hydroxyapatite / polyurethane bioscaffold and hydroxyapatite / polyurethane bioscaffold with and without ultrasound stimulation in Example 6 is shown.

[0032] Figure 6 The results of HIF-1α and VEGF expression in each group of rat femoral defect surgery 2 weeks after the operation in Example 8 are shown (400×). DETAILED DESCRIPTION

[0033] Example 1 45.0 g of polytetramethylene ether glycol (PTMEG, molecular weight 2000) was added to a three-necked flask filled with nitrogen and equipped with a stirring device, and then 11.2 g of isophorone diisocyanate (IPDI, molecular weight 222.28) was added, wherein the molar ratio of NCO in isocyanate to OH in polyol was ensured to be 2:1, and prepolymerization was carried out in a 70°C oil bath for 5 h, and then 2 mL of chain extender 1,4-butanediol and 2 drops of catalyst stannous octoate were added, and the reaction was continued under nitrogen protection with stirring for 2 h, and 0.5 ml of water was added as a blowing agent and the reaction was continued for 0.5 h, and finally, it was placed in a 90°C oven for aging for 24 h to obtain a porous polyurethane foam material.

[0034] The obtained foamed polyurethane was cut into particles with a particle size of about 10 mm, and dissolved in anhydrous ethanol after being fully dried. When the slurry viscosity was about 600 P·s, the slurry was transferred to the barrel of the 3D printer. A needle with a needle tip diameter of 210 μm was selected, and the relevant parameters of the 3D printer were set as follows: wire spacing 500 μm, layer height 200 μm, air pressure 5 MPa, and printing speed 5 mm / s. The receiving device was a culture dish filled with distilled water, and a porous three-dimensional polyurethane scaffold ( Figure 1 ). It can be found that the pores of the polyurethane scaffold are orderly and uniform, and the pore size can be adjusted by adjusting the printing parameters.

[0035] Example 2 45.0 g of polytetramethylene glycol (PTMEG, molecular weight 2000) was added to a three-necked flask filled with nitrogen and equipped with a stirring device, and then 11.4 g of L-lysine diisocyanate (LDI, molecular weight 226.22) was added (the molar ratio of NCO in isocyanate to OH in polyol was 2:1), and the reaction was prepolymerized in a 70°C oil bath for 5 h. Then, 4.4 g of chain extender L-lysine ethyl ester dihydrochloride and 2 drops of catalyst stannous octoate were added, and the reaction was continued under nitrogen protection with stirring for 2 h. 0.5 mL of water was added as a blowing agent and the reaction was continued for 0.5 h. Finally, the material was aged in an oven at 90°C for 24 h to obtain a porous polyurethane foam material.

[0036] The obtained foamed polyurethane was cut into particles with a particle size of about 10 mm, fully dried and dissolved in anhydrous ethanol. When the slurry viscosity was about 600 P·s, the slurry was transferred to the barrel of the 3D printer. A needle with a needle tip diameter of 210 μm was selected, and the relevant parameters of the 3D printer were set as follows: wire spacing 500 μm, layer height 200 μm, air pressure 5 MPa, and printing speed 5 mm / s. The receiving device was a culture dish filled with distilled water, and a porous three-dimensional polyurethane scaffold was obtained.

[0037] Example 3 11.25 g of polytetramethylene glycol (PTMEG, molecular weight 2000) and 11.25 g of polycaprolactone (PCL, molecular weight 2000) were added to a three-necked flask filled with nitrogen and equipped with a stirring device, and then 5.6 g of isophorone diisocyanate (IPDI, molecular weight 222.28) was added (the molar ratio of NCO in isocyanate to OH in polyol was 2:1), and prepolymerization was carried out in a 70°C oil bath for 4 h, and then 1 mL of chain extender 1,4-butanediol and 1 drop of catalyst stannous octoate were added, and the reaction was continued under nitrogen protection with stirring for 2 h, and 0.25 mL of water was added as a blowing agent to continue the reaction for 0.5 h, and finally, it was placed in a 90°C oven for aging for 24 h to obtain a porous polyurethane foam material.

[0038] The obtained foamed polyurethane was cut into particles with a particle size of about 10 mm. After being fully dried, 55 g was taken and dissolved in anhydrous ethanol. 45 g of hydroxyapatite powder was ultrasonically dispersed in anhydrous ethanol. After the polyurethane particles were fully dissolved, hydroxyapatite / anhydrous ethanol suspension was added and mechanically stirred for 2 h until the mixture was uniform. When the slurry viscosity was about 150 P·s, the slurry was transferred to the 3D printer barrel. A needle with a needle tip diameter of 210 μm was selected, and the relevant parameters of the 3D printer were set as follows: wire spacing 500 μm, layer height 150 μm, air pressure 5 MPa, and printing speed 5 mm / s to obtain a porous three-dimensional scaffold.

[0039] Example 4 The foamed polyurethane obtained in Example 1 was cut into particles with a particle size of about 10 mm. After being fully dried, 55 g was taken and dissolved in anhydrous ethanol. 45 g of hydroxyapatite powder was ultrasonically dispersed in anhydrous ethanol. After the polyurethane particles were fully dissolved, hydroxyapatite / anhydrous ethanol suspension was added and mechanically stirred for 2 h until the mixture was uniform. When the slurry viscosity was about 200 P·s, the slurry was transferred to the 3D printer barrel. A needle with a needle tip diameter of 210 μm was selected, and the relevant parameters of the 3D printer were set as follows: wire spacing 500 μm, layer height 100 μm, air pressure 5 MPa, printing speed 5 mm / s, and a porous three-dimensional scaffold (such as Figure 3 The scaffold is a regular cube. When the scaffold is enlarged, the surface of the scaffold is relatively rough, and the aggregated hydroxyapatite particles are half exposed on the surface of the scaffold. This morphology can provide a focus for cell adhesion, and the hydroxyapatite with bioaffinity directly contacts the cells, which is beneficial to improve the cell compatibility of the scaffold.

[0040] Example 5 The foamed polyurethane obtained in Example 1 was cut into particles with a particle size of about 10 mm. After being fully dried, 55 g was taken and dissolved in anhydrous ethanol. 45 g of silicon-substituted hydroxyapatite powder was ultrasonically dispersed in anhydrous ethanol. After the polyurethane particles were fully dissolved, the hydroxyapatite / anhydrous ethanol suspension was added and mechanically stirred for 2 h until the mixture was uniform. When the slurry viscosity was about 200 P·s, the slurry was transferred to the 3D printer barrel. A needle with a needle tip diameter of 0.5 μm was selected, and the relevant parameters of the 3D printer were set as follows: filament spacing of 700 μm, layer height of 150 μm, air pressure of 5 MPa, and printing speed of 8 mm / s to obtain a porous three-dimensional scaffold.

[0041] Example 6 The foamed polyurethane obtained in Example 1 was cut into particles with a particle size of about 10 mm. After being fully dried, 55 g was taken and dissolved in anhydrous ethanol. 25 g of hydroxyapatite powder and 20 g of nano-barium titanate were ultrasonically dispersed in anhydrous ethanol respectively. After the polyurethane particles were fully dissolved, hydroxyapatite / anhydrous ethanol suspension and barium titanate / anhydrous ethanol suspension were added. Mechanical stirring was performed for 2 h until the mixture was uniform. When the viscosity of the slurry was about 200 P·s, the slurry was transferred to the barrel of a 3D printer. A needle with a needle tip diameter of 210 μm was selected, and the relevant parameters of the 3D printer were set as follows: wire spacing of 500 μm, layer height of 200 μm, air pressure of 5 MPa, and printing speed of 5 mm / s to obtain a porous three-dimensional bracket. From the cross-sectional view of the bracket (as shown in FIG. Figure 4 As shown in the figure, it can be seen that there are pores between the layers of the scaffold, and this pore can be adjusted by modifying the printing model. The pores on the side are conducive to the transportation of nutrients and oxygen, and are more conducive to the growth of cells, and are also conducive to the discharge of waste. When the interior of the silk is magnified, it is found that there is no obvious agglomeration of inorganic particles, and the PU matrix can wrap the inorganic filler well. From the EDS results, it can also be found that the elements inside the scaffold are evenly distributed and there is no agglomeration phenomenon. After adding barium titanate to the "ink" and then applying ultrasound to the scaffold, the piezoelectric properties of the scaffold can be used to simultaneously apply mechanical and electrical stimulation to the cells on the scaffold, which is conducive to promoting cell mineralization. Figure 5 It is the result of polymerase chain reaction, which can reflect the expression of cell genes. It can be found that the piezoelectric effect produced by ultrasonic stimulation and barium titanate can synergistically promote the differentiation of bone marrow stromal stem cells into osteoblasts. The addition of barium titanate gives the scaffold piezoelectric properties, and this electrical signal stimulation has a positive effect on the mineralization of cells.

[0042] Example 7 The foamed polyurethane obtained in Example 1 was cut into particles with a particle size of about 10 mm. After being fully dried, 55 g was taken and dissolved in anhydrous ethanol. 25 g of hydroxyapatite powder and 20 g of nano-silicon dioxide were ultrasonically dispersed in anhydrous ethanol respectively. After the polyurethane particles were fully dissolved, hydroxyapatite / anhydrous ethanol suspension and silicon dioxide / anhydrous ethanol suspension were added, and mechanical stirring was performed for 2 h until the mixture was uniform. When the slurry viscosity was about 200 P·s, the slurry was transferred to the 3D printer barrel. A needle with a needle tip diameter of 210 μm was selected, and the relevant parameters of the 3D printer were set as follows: wire spacing 500 μm, layer height 200 μm, air pressure 5MPa, and printing speed 5 mm / s to obtain a porous three-dimensional bracket.

[0043] Example 8 The foamed polyurethane obtained in Example 1 was cut into particles with a particle size of about 10 mm. After being fully dried, 55 g was taken and dissolved in anhydrous ethanol. 25 g of hydroxyapatite powder and 20 g of deferoxamine were ultrasonically dispersed in anhydrous ethanol respectively. After the polyurethane particles were fully dissolved, hydroxyapatite / anhydrous ethanol suspension and deferoxamine / anhydrous ethanol suspension were added. Mechanical stirring was performed for 2 h until the mixture was uniform. When the viscosity of the slurry was about 200 P·s, the slurry was transferred to the barrel of a 3D printer. A needle with a needle tip diameter of 0.21 μm was selected, and the relevant parameters of the 3D printer were set as follows: wire spacing of 500 μm, layer height of 200 μm, air pressure of 5 MPa, and printing speed of 5 mm / s to obtain a porous three-dimensional scaffold. The scaffold was implanted into the femoral defect of rats, and the results of immunohistochemical staining (such as Figure 6 As shown in the figure, it is obvious that the expression of HIF-1α and VEGF receptors related to angiogenic differentiation increased after the addition of deferoxamine, which indicates that the addition of deferoxamine endows the stent with certain angiogenic function.

[0044] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.

Claims

1. A biological scaffold material based on 3D printing, characterized in that: It is in a fluid state at room temperature; And includes, by weight, linear polyurethane, hydroxyapatite, inorganic nanofiller, drug and solvent; Hydroxyapatite accounts for 0-50wt% of the total mass; Inorganic nanofillers account for 0-30wt% of the total mass; The mixture of drug and solvent accounts for 0-5wt% of the total mass; The balance is linear polyurethane.

2. The 3D printing-based biological scaffold material according to claim 1, characterized in that: The linear polyurethane is polymerized by hard segment material of aliphatic diisocyanate and soft segment material of diol polymer and / or block copolymer containing hydroxyl group, and the molecular weight of the linear polyurethane is 10000-100000; The molar ratio of the isocyanate group in the hard segment material to the hydroxyl group in the soft segment material is (2-4):1; The hard segment material includes at least one of isophorone diisocyanate, 4,4'-dicyclohexylmethane diisocyanate and lysine diisocyanate; The soft segment component is a linear diol with a molecular weight of 1000-20000, including at least one of polycaprolactone diol, polylactic acid diol, polyglycolide diol and polylactic acid-glycolic acid copolymer diol.

3. The 3D printing-based biological scaffold material according to claim 1, characterized in that: Hydroxyapatite includes basic apatite, carbonate hydroxyapatite, and silicate-substituted hydroxyapatite; Hydroxyapatite is spherical with a diameter of 10-1000nm; Granular with a particle size of 10-1000nm; Flakes with a diameter of 10-100nm and a thickness of 10-50nm; One or more nanocrystals in the shape of rods with a diameter of 10-100nm and a length of 10-500nm.

4. The 3D printing-based biological scaffold material according to claim 1, characterized in that: The inorganic nano filler is silicon dioxide and nano barium titanate with a particle size less than 1000 nm, and the particle size is 100-500 nm.

5. The 3D printing-based biological scaffold material according to claim 1, characterized in that: The drug is deferoxamine.

6. The 3D printing-based biological scaffold material according to claim 1, characterized in that: The solvent is at least one of deionized water, ethanol, chloroform, trifluoroethanol, chloroform, dichloromethane, hexafluoroisopropanol, tetrahydrofuran, acetone, N,N-dimethylformamide and N,N-dimethylacetamide.

7. The 3D printing-based biological scaffold material according to claim 1, characterized in that: Its apparent viscosity is 100-1000 Pa·s.

8. A method for preparing a biological scaffold material based on 3D printing, characterized in that: For preparing the biological scaffold material as claimed in claim 2, comprising the steps of: Step A1, the hard segment material and the soft segment material are stirred and reacted at 60-110° C. for 2-6 hours under nitrogen protection; Step A2, adding a chain extender with a molar mass of 1:(1-2) of the soft segment material and a catalyst with a molar mass of 0.01-0.05 wt% of the mass of the soft segment material to react for 1-5 hours; Step A3, adding 0.1-1 mL of deionized water and performing a foaming reaction at 90-110° C. for 2-24 hours to obtain a foamed polyurethane; Step A4, cutting the foamed polyurethane into granules, drying and then putting them into a solvent, so that the granular foamed polyurethane is dissolved in the solvent; Step A5, treating the hydroxyapatite and the inorganic nanofiller with a silane coupling agent at 90-110° C. for 2-5 hours respectively; Step A6, adding hydroxyapatite and inorganic nanofiller to the solution obtained in step A4 and dispersing by ultrasonication; Step A7, adding the drug to the solution obtained in step A5, and waiting for the drug to dissolve to obtain a bioscaffold preparation material; The general formula of the silane coupling agent is RSiX3, wherein R represents an amino group, a thiol group, a vinyl group, an epoxy group, a cyano group, and a methacryloxy group, and X represents a hydrolyzable group; The chain extender is at least one of lysine ethyl ester dihydrochloride, 1,4-butanediol, ethylene glycol and 1,6-hexanediol; The catalyst is at least one of dibutyltin dilaurate, stannous octoate and stannous chloride.

9. A biological scaffold based on 3D printing, characterized in that: An ordered porous scaffold prepared by using the 3D printing-based biological scaffold material as described in claim 1 and by using deposition 3D printing; The ordered porous scaffold has longitudinal through holes with a pore size of 50-1000 μm and transverse through holes with a pore size of 10-1000 μm; The ordered porous scaffold material has a density of 50-100 kg / m 3 , elastic material with porosity of 0-90% and compression strength of 0.5-5MPa.

10. A method for preparing a biological scaffold based on 3D printing, characterized in that: The 3D printing-based biological scaffold material as described in claim 1 is added into the barrel of a 3D printer, and the biological scaffold is prepared by a 3D printer. During the preparation, the prepared scaffold is received by a container containing a solvent for replacing and curing the biological scaffold material, and the operating parameters are: The layer height of the printed model is 0.1-1mm; The diameter of the printing wire is 0.21-1mm; The printing wire spacing is 0-1mm; The printer needle pressure is 1-5MPa; The needle running speed is 0.1-8mm / s; The slurry bin temperature is 0-60℃; The receiving plate temperature is -10-50℃; The ambient temperature is 10-40℃; Relative humidity is 20-70%.

Citation Information

Cited By

  • 3D printing rapid curing method suitable for hydrogen-bond-rich polymer and biological scaffold of hydrogen-bond-rich polymer

    CN121197521A